枢纽生物标志物及其在糖代谢障碍中的临床相关性:全面的生物信息学和机器学习方法
Liping Xiang1,2, Bing Zhou1,2, Yunchen Luo3
1Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Chinese medical journal
|June 20, 2025
概括
这项研究确定了骨质模块素 (OMD),阿波利波蛋白A4 (APOA4) 和胰岛素样生长因子结合蛋白6 (IGFBP6) 作为葡萄糖生成相关代谢障碍的关键生物标志物,为诊断和治疗提供了新的途径.
科学领域:
- 代谢途径 代谢途径
- 发现生物标志物的发现.
- 基因组学就是基因组学.
背景情况:
- 葡萄糖生成对葡萄糖平衡至关重要;其失调会导致代谢障碍.
- 识别可靠的生物标志物对于诊断和治疗这些疾病至关重要.
研究的目的:
- 为了确定与葡萄糖生成相关的糖代谢障碍的枢纽生物标志物.
- 为改善诊断和治疗策略提供基础.
主要方法:
- 在葡萄糖生成的小鼠模型中分析基因表达特征.
- 权重基因同表达网络分析 (WGCNA) 和机器学习的应用.
- 使用2型糖尿病 (T2DM) 患者的转录组数据进行验证.
主要成果:
- 常见的差异表达基因 (DEGs) 与细胞因子调节和氧化应激 (OS) 有关.
- 鉴定出了骨质模块素 (OMD),阿波利波蛋白A4 (APOA4) 和IGFBP6作为潜在的临床生物标志物.
- 这些生物标志物在T2DM患者中显示出诊断价值,与免疫细胞相关.
结论:
- 葡萄糖生成障碍是异质的,但共享改变的细胞因子调节和OS.
- OMD,APOA4和IGFBP6是这些糖代谢障碍的有希望的枢纽生物标志物.
更多相关视频
相关概念视频
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...


